TELMICHEK 40 10

About

TELMICHEK 40 contains telmisartan, an angiotensin II receptor blocker (ARB), indicated for the treatment of essential hypertension and for reducing the risk of cardiovascular morbidity and mortality in high-risk patients. Telmisartan works by selectively blocking the AT1 receptor, preventing the vasoconstrictive and aldosterone-releasing effects of angiotensin II. This action results in vasodilation, decreased peripheral vascular resistance, and reduced sodium and water retention, leading to a significant reduction in blood pressure. Its prolonged duration of action ensures consistent blood pressure control over 24 hours, making it an effective once-daily treatment. Furthermore, telmisartan has demonstrated benefits in protecting target organs, particularly the kidneys, in hypertensive patients with diabetes.

Uses

• Treatment of high blood pressure.
• Reduction of cardiovascular risk in adults aged 55 years or older.
• Prevention of stroke and heart attack.
• Management of hypertension in patients with type 2 diabetes.

Directions For Use

Take one tablet orally once daily, with or without food, as prescribed by your healthcare provider.

Benefits

• Effectively lowers and maintains healthy blood pressure levels.
• Significantly reduces the risk of major cardiovascular events.
• Provides sustained 24-hour blood pressure control.
• Offers protective effects for the kidneys, especially in diabetic patients.
• Has a low incidence of dry cough compared to ACE inhibitors.
• Convenient once-daily dosing regimen.

Side Effects

• Dizziness
• Headache
• Fatigue
• Low blood pressure
• Back pain
• Nausea
• Diarrhea
• Upper respiratory tract infection
• Elevated potassium levels
• Fainting spells
• Swelling of face or throat (rare)
• Impaired kidney function (in vulnerable individuals)

Safety Measures

• Alcohol - Alcohol consumption may potentiate the hypotensive effects of telmisartan, leading to increased dizziness or lightheadedness. Use with caution.
• Pregnancy - Telmisartan is contraindicated during the second and third trimesters of pregnancy due to the risk of serious fetal injury and death.
• Breastfeeding - Telmisartan is excreted in breast milk. It is not recommended for use during breastfeeding.
• Liver - Use with caution in patients with severe hepatic impairment or biliary obstructive disorders, as telmisartan is primarily eliminated through bile.
• Kidney - Exercise caution in patients with renal artery stenosis or severe renal impairment, as it may lead to a decline in kidney function.
• Lung - Generally considered safe for use in patients with lung conditions, as it does not typically impact respiratory function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.